West Midlands AHSN supports use of digital chest drainage

West Midlands AHSN supports use of digital chest drainage
Birmingham Community Healthcare will provide a unified child health information service for the West Midlands using System C’s CarePlus.

The West Midlands Academic Health Science Network (WMAHSN) is supporting a new digital healthcare innovation which helps patients who are recovering from lung surgery or experiencing a collapsed lung.

Thopaz+ is a portable digital chest drainage and monitoring system, which enables patients to be monitored via digital readings. This supports patients’ recovery and helps to reduce the length of their stay in hospital.

The new digital solution streamlines the current process for monitoring patients’ rate of air leak and fluid drainage. By showing this data digitally, it helps support effective clinical decision making, improves patient safety and provides a cost-effective solution.

In addition, when compared to conventional chest drains, patients are able to get up out of bed much earlier, as Thopaz+ is portable, which aids recovery.

Dr Joseph Robinson, WMAHSN innovation project manager and AHSN national lead for Thopaz+, said: “Thopaz+ is a fantastic healthcare innovation that we are pleased to be supporting as part of the MedTech Funding Mandate Policy.

“Being digital and portable, the device aids clinical decision making with objective data, and it has also been demonstrated as cost-saving by the National Institute for Health and Care Excellence. It will bring numerous benefits to both NHS staff and patients, and we hope to support equitable patient access across the West Midlands and nationally.”

Through the MedTech Funding Mandate (MTFM) Policy the WMAHSN will support NHS providers to implement Thopaz+ in the West Midlands.

The policy was developed by the Accelerated Access Collaborative, part of NHS England and NHS Improvement, and helps accelerate patient access to innovation, supporting the NHS Long Term Plan

Thopaz+ was one of seven new technologies added to the MTFM 2022/23, and one of three which focuses on the patient experience during procedures.

The MTFM policy came into effect on 1 April 2021 and has previously been used to mandate for an AI-powered tool to fight coronary heart disease.

Subscribe to our newsletter

Subscribe To Our Newsletter

Subscribe To Our Newsletter

Sign up

Related News

NICE recommends two technologies for tics and Tourette syndrome

NICE recommends two technologies for tics and Tourette syndrome

NICE has recommend two technologies that could reduce the severity of the symptoms of chronic tic disorders and Tourette syndrome.
Insomnia app unavailable for most of NHS despite NICE approval

Insomnia app unavailable for most of NHS despite NICE approval

Big Health says that its app to treat insomnia is unavailable to most NHS patients despite being recommended by NICE over two years ago.
Trial finds digital avatars reduce distressing voices in psychosis

Trial finds digital avatars reduce distressing voices in psychosis

A trial has found that digital avatars can help people with psychosis reduce the distress and frequency with which they hear voices.